Moving beyond race-based drugs

Prescribing certain medications on the basis of a patient's race has long come under fire from those uneasy with using race as a surrogate for biology when treating disease. But there are multiple challenges to overcome before we can move beyond race-based treatment decisions, writes a geneticist and a bioethicist in a new perspective piece.